Mucosal tenascin C content in inflammatory and neoplastic diseases of the large bowel

Diseases of the Colon and Rectum

Volumn 41, Issue 1, 1998, Pages 86-92

  Riedl, Stefan ^a   Kadmon, Martina ^a   Tandara, Andrea ^a   Hinz, Ulf ^a   Möller, Peter ^a   Herfarth, Christian ^a   Faissner, Andreas ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Colon adenoma; Colon carcinoma; Tenascin C; Tissue concentration; Ulcerative colitis

Indexed keywords

TENASCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON ADENOMA; COLORECTAL CARCINOMA; EXTRACELLULAR MATRIX; FAMILIAL POLYPOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LARGE INTESTINE CANCER; MALE; MALIGNANT TRANSFORMATION; PROCTOCOLECTOMY; PROTEIN ANALYSIS; QUANTITATIVE DIAGNOSIS; ULCERATIVE COLITIS; WOUND HEALING;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CHILD; COLITIS, ULCERATIVE; COLONIC DISEASES; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; TENASCIN;

EID: 0031973527     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02236901     Document Type: Article

References (27)

1. Erickson HP, Iglesias JL. A six-armed oligomer isolated from cell surface fibronectin preparations. Nature 1984; 311:267-9.
2. Erickson HP. Evolution of the tenascin family - implications for function of the C-terminal fibrinogen-like domain. Perspect Dev Neurobiol 1994;2:9-19.
3. Chiquet-Ehrismann R, Hagios C, Matsumoto K. The tenascin gene family. Perspect Dev Neurobiol 1994;2:3-7.
4. Faissner A, Götz B, Joester A, Scholze A. The tenascin gene family - versatile glycoproteins implicated in neural pattern formation and regeneration. Semin Dev Biol 1995;6:139-48.
5. Faissner A, Steindler D. Boundaries and inhibitory molecules in developing neural tissues. Glia 1995;13: 233-54.
6. Erickson HP, Bourdon MA. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol 1989;5:71-92.
7. Koukoulis GK, Gould VE, Bhattacharyya A, Gould JE, Howeedy AA, Virtanen I. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues. Hum Pathol 1991; 22:636-43.
8. Natali PG, Nicotra MR, Bigotti A, et al. Comparative analysis of the expression of the extracellular matrix protein tenascin in normalfetal, adult and tumor tissues. Int J Cancer 1991;47:811-6.
9. Aufderheide E, Ekblom P. Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions. J Cell Biol 1988;107:2341-9.
10. Beaulieu J-F, Jutras S, Kusakabe M, Perreault N. Expression of tenascin in the developing human small intestine. Biochem Biophys Res Commun 1993;192: 1086-92.
11. Riedl SE, Faissner A, Schlag P, von Herbay A, Koretz K, Möller P. Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma. Gastroenterology 1992;103:400-6.
12. Probstmeier R, Martini R, Schachner M. Expression of J1/tenascin in the crypt-villus unit of adult mouse small intestine: implications for its role in epithelial cell shedding. Development 1990;109:313-21.
13. Sakai T, Kawakatsu H, Hirota N, Yokoyama T, Sakakura T, Saito M. Specific expression of tenascin in human colonie neoplasms. Br J Cancer 1993;67:1058-64.
14. Lightner VA, Slemp CA, Erickson HP. Localization and quantitation of hexabrachion (tenascin) in skin, embryonic brain, tumors, and plasma. Ann N Y Acad Sci 1990;580:260-75.
15. Ventimiglia JB, Wikstrand CJ, Ostrowski LE, Bourdon MA, Lightner VA, Bigner DD. Tenascin expression in human glioma cell lines and normal tissues. J Neuroimmunol 1992;36:41-55.
16. Ibrahim SN, Lightner VA, Ventimiglia JB, et al. Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma. Hum Pathol 1994;24:982-9.
17. Zagzag D, Friedlander DR, Miller DC, et al. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res 1995;55:907-14.
18. Rachmilewitz D. Coated mesalazine(5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989;298: 82-6.
19. Truelove SC, Richards WC. Biopsy studies in ulcerative colitis. BMJ 1956;1:1315-8.
20. Faissner A, Kruse J. J1/Tenascin is a repulsive substrate for central nervous system neurons. Neuron 1990;5: 627-37.
21. Riedl S, Bodenmüller H, Hinz U, et al. Significance of tenascin serum level as tumor marker in primary colorectal carcinoma. Int J Cancer 1995;64:65-9.
22. Sugawara I, Hirakoshi J, Masunaga A, Itoyama S, Sakakura T. Reduced tenascin expression in colonic carcinoma with lymphogenous metastasis. Invasion Metastasis 1991;11:325-31.
23. Sugawara I, Hirakoshi J, Kusakabe M, Masunaga A, Itoyama S, Sakakura T. Relationships among tenascin expression, DNA ploidy patterns, and multidrug resistance gene product (p-glycoprotein) in human colon carcinoma. Jpn J Cancer Res 1993;84:703-7.
24. Ekblom P, Aufderheide E. Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions. Int J Dev Biol 1989;33:71-9.
25. Young SL, Chang L-Y, Erickson HP. Tenascin C in rat lung: distribution, ontogeny and role in branching morphogenesis. Dev Biol 1994;161:615-25.
26. Schalkwijk J, Steijlen PM, Vlijmen-Willems IM, Oosterling B, Mackie EJ, Verstraeten AA. Tenascin expression in human dermis is related to epidermal proliferation. Am J Pathol 1991;139:1143-50.
27. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988;107:2757-67.